drugset / Trial / NCT00233623

Irinotecan, 5-Fluorouracil and Leucovorin With or Without Iressa in the Treatment of Metastatic Colorectal Cancer

NCT00233623 ↗

Phase 2 Withdrawn 190 enrolled AstraZeneca
RandomizedParallel-groupOpen-labelTreatment

Summary

The aim of the study is to determine if Iressa added to chemotherapy with Irinotecan, 5Fluorouracil and Leucovorin can prolong the period of time without any disease worsening (Time to Progression) in patients with metastatic colorectal cancer.

Timeline

Start
2004-07
Primary completion
2006-01
Completion
2006-01

Drugs

EvaluationDrugModalityDoseRoute
Subject Gefitinib Small molecule — —
Background Irinotecan Small molecule — —
Background Leucovorin Small molecule — —
Background fluorouracil Small molecule — —

Indications